Viola Brugnatelli

Viola Brugnatelli is a neuropharmacologist with over a decade of experience in the field of medical

cannabis. Her research journey began in 2012 at NHS (Scotland), where she

investigated novel cannabinoid receptors, and continued at University College Dublin (Ireland),

focusing on the role of CBD in inflammatory processes.

In 2017, she successfully launched a training course on endocannabinoid science at the Department

of Neuroscience at the University of Padua. In 2018, she co-founded Cannabiscienza Srl, Italy’s

leading institution dedicated to scientific cannabis education for healthcare professionals,

establishing the largest trained network of doctors, veterinarians, and pharmacists on medical

cannabis in Europe. In 2022, she expanded this mission internationally by founding

Cannabiscientia SA in Switzerland.

Viola is the author of numerous scientific articles, reports, and reference manuals for prescribers and

researchers. In addition to her work in research and education, she plays a pivotal role in translating

complex cannabis science into actionable frameworks for the regulatory, healthcare, and economic

sectors. She is a frequent public speaker at industry events and scientific conferences, where she

shares her strategic vision and dedication to aligning patient needs, medical innovation, and

financial opportunity.

Viola’s mission stems from a deeply personal story: the loss of her seventeen-year-old sister due to

a chemotherapy side effect (hypokalemia caused by uncontrollable vomiting). Medical cannabis,

now reimbursed in Italy as a palliative oncology treatment by the national health service, could have

saved her life. This profound sense of justice has fuelled Viola’s commitment to education—so that

no patient should suffer needlessly from a lack of effective treatment.